Home REIT PLC
24 July 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
THIS STATEMENT IS MADE WITHOUT WAIVER OF LEGAL PRIVILEGE
24 July 2026
Home REIT plc
("HOME" or the "Company")
Dispute with Smith Square Partners LLP
The Company today provides an update on a commercial dispute with Smith Square Partners LLP.
Smith Square Partners LLP were appointed by the Company in early 2023 to provide the Board with specific strategic advice. Their appointment terminated with effect from 24 November 2023.
Smith Square Partners LLP this week issued proceedings regarding a purported unpaid contractual debt of £1,623,600 together with contractual interest, further or other relief, and costs (the "Claim").
The Claim alleges that the Company's RNS of 13 November 2025, responding to press speculation concerning the Company's portfolio sales process, triggered a tail fee payable within the 24-month period following termination of Smith Square Partners LLP's appointment. On 2 March 2026 the board announced the Company had exchanged on the disposal of 706 properties, representing the majority of the Company's portfolio of assets, to Patron Capital. The Company intends to vigorously defend the Claim.
FOR FURTHER INFORMATION, PLEASE CONTACT:
|
FTI Consulting (Communications Adviser) Dido Laurimore Bryn Woodward |
+44 (0)20 3727 1000 |
The Company's LEI is: 213800A53AOVH3FCGG44.
For more information, please visit the Company's website: www.homereituk.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.